Movatterモバイル変換

[0]ホーム
URL:

GB1533243A - Tablet formulation - Google Patents

Tablet formulation

Info

Publication number
GB1533243A
GB1533243AGB6174/75AGB617475AGB1533243AGB 1533243 AGB1533243 AGB 1533243AGB 6174/75 AGB6174/75 AGB 6174/75AGB 617475 AGB617475 AGB 617475AGB 1533243 AGB1533243 AGB 1533243A
Authority
GB
United Kingdom
Prior art keywords
tablet formulation
sulphonamide
feb
disintegrating agent
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB6174/75A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation LtdfiledCriticalWellcome Foundation Ltd
Priority to GB6174/75ApriorityCriticalpatent/GB1533243A/en
Priority to DK57376*#Aprioritypatent/DK57376A/en
Priority to NL7601423Aprioritypatent/NL7601423A/en
Priority to IL7649024Aprioritypatent/IL49024A/en
Priority to JP51014332Aprioritypatent/JPS51106711A/ja
Priority to HU76WE00000534Aprioritypatent/HU171201B/en
Priority to DE19762605656prioritypatent/DE2605656A1/en
Priority to ZA760829Aprioritypatent/ZA76829B/en
Priority to CA245,882Aprioritypatent/CA1052267A/en
Priority to IE272/76Aprioritypatent/IE42952B1/en
Priority to FI760340Aprioritypatent/FI760340A7/fi
Priority to FR7603829Aprioritypatent/FR2300550A1/en
Priority to BE164281Aprioritypatent/BE838507A/en
Priority to SE7601564Aprioritypatent/SE7601564L/en
Priority to AU11108/76Aprioritypatent/AU495948B2/en
Publication of GB1533243ApublicationCriticalpatent/GB1533243A/en
Expiredlegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

1533243 Tablets containing sulphonamides WELLCOME FOUNDATION Ltd 13 Feb 1976 [13 Feb 1975] 6174/75 Heading A5B A tablet comprises from 80-98% (w/w) of a sulphonamide, a disintegrating agent and a granulating agent, the total amount of both agents being from 2-20% (w/w), wherein the particle size (as defined) of the sulphonamide is less than 40Ám and the disintegrating agent has a swelling capacity (as defined) greater than 5 ml/g.
GB6174/75A1975-02-131975-02-13Tablet formulationExpiredGB1533243A (en)

Priority Applications (15)

Application NumberPriority DateFiling DateTitle
GB6174/75AGB1533243A (en)1975-02-131975-02-13Tablet formulation
DK57376*#ADK57376A (en)1975-02-131976-02-12 THE SULPHONE CABLE
NL7601423ANL7601423A (en)1975-02-131976-02-12 PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION.
IL7649024AIL49024A (en)1975-02-131976-02-12Sulphonamide tablet formulations
JP51014332AJPS51106711A (en)1975-02-131976-02-12
HU76WE00000534AHU171201B (en)1975-02-131976-02-12Process for preparing pharmaceutical preparations containing sulphonamides
DE19762605656DE2605656A1 (en)1975-02-131976-02-12 PHARMACEUTICAL PREPARATIONS IN TABLET FORM
ZA760829AZA76829B (en)1975-02-131976-02-12Tablet formulation
CA245,882ACA1052267A (en)1975-02-131976-02-12Table formulation
IE272/76AIE42952B1 (en)1975-02-131976-02-12Tablet formulation
FI760340AFI760340A7 (en)1975-02-131976-02-12
FR7603829AFR2300550A1 (en)1975-02-131976-02-12 ANTIMICROBIAL DRUG
BE164281ABE838507A (en)1975-02-131976-02-12 PHARMACEUTICAL TABLETS
SE7601564ASE7601564L (en)1975-02-131976-02-12 WAY TO MAKE TABLETS
AU11108/76AAU495948B2 (en)1975-02-131976-02-13Tablet formulation

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GB6174/75AGB1533243A (en)1975-02-131975-02-13Tablet formulation

Publications (1)

Publication NumberPublication Date
GB1533243Atrue GB1533243A (en)1978-11-22

Family

ID=9809772

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB6174/75AExpiredGB1533243A (en)1975-02-131975-02-13Tablet formulation

Country Status (14)

CountryLink
JP (1)JPS51106711A (en)
BE (1)BE838507A (en)
CA (1)CA1052267A (en)
DE (1)DE2605656A1 (en)
DK (1)DK57376A (en)
FI (1)FI760340A7 (en)
FR (1)FR2300550A1 (en)
GB (1)GB1533243A (en)
HU (1)HU171201B (en)
IE (1)IE42952B1 (en)
IL (1)IL49024A (en)
NL (1)NL7601423A (en)
SE (1)SE7601564L (en)
ZA (1)ZA76829B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4524060A (en)*1981-05-211985-06-18John Wyeth & Brother LimitedSlow release pharmaceutical composition
US5556639A (en)*1991-01-301996-09-17Glaxo Wellcome Inc.Water-dispersible tablets
US5629016A (en)*1991-01-301997-05-13Glaxo Wellcome Inc.Water-dispersible tablets
US5698226A (en)*1993-07-131997-12-16Glaxo Wellcome Inc.Water-dispersible tablets
US8173161B2 (en)2002-12-042012-05-08Mcneil-Ppc, Inc.Method of administering a pharmaceutical active ingredient

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB1601833A (en)*1978-02-061981-11-04Wellcome FoundAntacid formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB1460302A (en)*1973-05-231977-01-06Wellcome FoundTablet formulation
GB1499672A (en)*1974-02-141978-02-01Wellcome FoundTablet formulation

Cited By (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4524060A (en)*1981-05-211985-06-18John Wyeth & Brother LimitedSlow release pharmaceutical composition
US5556639A (en)*1991-01-301996-09-17Glaxo Wellcome Inc.Water-dispersible tablets
US5629016A (en)*1991-01-301997-05-13Glaxo Wellcome Inc.Water-dispersible tablets
US5660860A (en)*1991-01-301997-08-26Glaxo Wellcome Inc.Water-dispersible tablets
US5698226A (en)*1993-07-131997-12-16Glaxo Wellcome Inc.Water-dispersible tablets
US8173161B2 (en)2002-12-042012-05-08Mcneil-Ppc, Inc.Method of administering a pharmaceutical active ingredient

Also Published As

Publication numberPublication date
JPS51106711A (en)1976-09-21
NL7601423A (en)1976-08-17
DK57376A (en)1976-08-14
AU1110876A (en)1977-08-18
IL49024A (en)1979-03-12
IL49024A0 (en)1976-04-30
FR2300550A1 (en)1976-09-10
HU171201B (en)1977-11-28
ZA76829B (en)1977-09-28
IE42952L (en)1976-08-13
BE838507A (en)1976-08-12
IE42952B1 (en)1980-11-19
FR2300550B1 (en)1979-09-21
SE7601564L (en)1976-08-16
CA1052267A (en)1979-04-10
DE2605656A1 (en)1976-08-26
FI760340A7 (en)1976-08-14

Similar Documents

PublicationPublication DateTitle
AU576197B2 (en)Particulate n-acetyl-p-aminophenol composition
GB1341514A (en)
IE790209L (en)Antacid formulation
GB1390803A (en)Medicinal tampons and compositions containing lactulose
IE802305L (en)Tablets
GB1533243A (en)Tablet formulation
GB1492687A (en)Water-soluble lubricant in tabletting compositions
ES269650A1 (en)Silica-gel powder tablet compositions
IL51616A0 (en)N-(5-tetrazolyl)-4-oxo-4h-pyrimido(2,1-b)benzothiazole-3-carboxamides and pharmaceutical compositions containing them
GB1457546A (en)Pharmaceutical preparations comprising cephalosporin derivatives
GB1499672A (en)Tablet formulation
GB1445983A (en)Pharmaceutical formulations
USD254257S (en)Rock crusher table liner
GB1153324A (en)Sustained Release Tablets
GB1439240A (en)Chewable aspirin tablet
GB1298587A (en)Methods of contraception and contraceptive compositions
GB1444944A (en)1-2-pyridyl-piperazine and levodopa composition
GB1465771A (en)Pharmaceutical composition and use thereofd
GB889377A (en)Tapeworm control agents
GB805393A (en)Dry powder fire-extinguishing medium
GB1233150A (en)
USD221004S (en)Combined swivel base and indexfor desk telephones
GB1509778A (en)Pharmaceutical composition and dosage units thereof
AU476756B2 (en)PHARMACOLOGICALLY ACTIVE 4, 8-DIMETHOXY-FURO-(3',2'-F) BENZOXAZOL-2-yl ACETHYDROXAMIC ACID
ES383340A1 (en)P-(acetoacetamidoalkyl)benzenesulfonamide derivatives

Legal Events

DateCodeTitleDescription
PSPatent sealed [section 19, patents act 1949]
PCNPPatent ceased through non-payment of renewal fee
[8]ページ先頭
©2009-2025 Movatter.jp